Teladoc,Inc. (NYSE:TDOC) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01.Entry Into a Material Definitive Agreement.
Teladoc, Inc. (the Company) has entered into an amendment, dated
December 27, 2016 (the Amendment), to its Employment Agreement
with Mr. Mark Hirschhorn, the Companys Executive Vice President,
Chief Operating Officer and Chief Financial Officer, that: (i)
reflects a previously reported change to Mr.Hirschhorns officer
title; (ii) establishes that Mr. Hirschhorn will be eligible for
discretionary annual bonuses in an amount determined by the
Companys Board of Directors (or Compensation Committee thereof)
with a target bonus equal to sixty-five percent (65%) of Mr.
Hirschhorns then-applicable base salaryunless the Board (or the
Compensation Committee thereof) determines otherwise; (iii)
modifies the vesting schedule of certain stock options held by
Mr. Hirschhorn; and (iv) makes certain conforming and other
changes and corrections of typographical errors.
The foregoing summary description of the Amendment does not
purport to be complete and is subject to, and qualified in its
entirety by reference to, the full text of such document that is
filed as Exhibit 10.1 to this Current Report on Form 8-K and is
incorporated herein by reference.
Item9.01.Financial Statements and Exhibits.
(d)Exhibits.
|
ExhibitNo. |
Description |
|
10.1 |
Amendment No. 1 to Executive Employment Agreement, dated |
2
About Teladoc, Inc. (NYSE:TDOC)
Teladoc, Inc., together with its subsidiaries, is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company operates through health services segment. Its solution connects its Members, with its over 3,000 board-certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. Its enterprise scale platform is offered for real-time sharing of clinical and non-clinical data in real time among the Teladoc constituents, which include Members, Providers, physician network operations center staff, nurses, SureScripts for electronic medication prescription writing, routing and fulfillment and health plans for claims processing, clinical summaries and clinical alerts. Teladoc, Inc. (NYSE:TDOC) Recent Trading Information
Teladoc, Inc. (NYSE:TDOC) closed its last trading session down -0.15 at 16.50 with 248,327 shares trading hands.
